In the 21st century, there must be a better way to treat cancer than chemotherapy, with all of its side effects. One method currently in development is T cell vector drug delivery. In this TEDtalk, UNC-Chapel Hill biochemist Elizabeth Wayne, Ph.D., describes using immune cells for cancer drug delivery through a combination of e-selectin and TRAIL (TNF-related apoptosis-inducing ligand). 


Previous articleInfluenza Prompts RNA-Targeting Response from Immune System
Next articleCancer Genetics Reports Record Q3 Revenue